Witnessing the stock’s movement on the chart, on Thursday, InMed Pharmaceuticals Inc (NASDAQ: INM) had a quiet start as it plunged -9.46% to $0.34, before settling in for the price of $0.37 at the close. Taking a more long-term approach, INM posted a 52-week range of $0.29-$2.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 55.92% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 39.17%. This publicly-traded company’s shares outstanding now amounts to $3.33 million, simultaneously with a float of $3.28 million. The organization now has a market capitalization sitting at $1.12 million. At the time of writing, stock’s 50-day Moving Average stood at $0.3622, while the 200-day Moving Average is $0.5868.
InMed Pharmaceuticals Inc (INM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. InMed Pharmaceuticals Inc’s current insider ownership accounts for 1.56%, in contrast to 24.16% institutional ownership. According to the most recent insider trade that took place on Feb 21 ’24, this organization’s Director bought 37,500 shares at the rate of 0.39, making the entire transaction reach 14,625 in total value, affecting insider ownership by 38,258. Preceding that transaction, on Feb 20 ’24, Company’s President & CEO bought 41,600 for 0.36, making the whole transaction’s value amount to 14,922. This particular insider is now the holder of 43,959 in total.
InMed Pharmaceuticals Inc (INM) Earnings and Revenue Records
As on 6/29/2022, Multinational firm has announced its last quarter scores, in which it reported -$14.03 earnings per share (EPS) for the period falling under the consensus outlook (set at -$5.5) by -$8.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
InMed Pharmaceuticals Inc (NASDAQ: INM) Trading Performance Indicators
Let’s observe the current performance indicators for InMed Pharmaceuticals Inc (INM). It’s Quick Ratio in the last reported quarter now stands at 6.58. The Stock has managed to achieve an average true range (ATR) of 0.04. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.20.
In the same vein, INM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.65.
Technical Analysis of InMed Pharmaceuticals Inc (INM)
Going through the that latest performance of [InMed Pharmaceuticals Inc, INM]. Its last 5-days volume of 0.5 million indicated improvement to the volume of 0.27 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 25.92% While, its Average True Range was 0.0444.
Raw Stochastic average of InMed Pharmaceuticals Inc (INM) in the period of the previous 100 days is set at 19.19%, which indicates a major rise in contrast to 16.72% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 76.70% that was lower than 84.43% volatility it exhibited in the past 100-days period.
